COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Miller, L.E.; Bhattacharyya, R.; Miller, A.L. Data regarding country-specific variability in Covid-19 prevalence, incidence, and case fatality rate. Data Brief 2020, 32, 106276. [Google Scholar] [CrossRef] [PubMed]
- Angeles, M.R.; Wanni Arachchige Dona, S.; Nguyen, H.D.; Le, L.K.-D.; Hensher, M. Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan. BMC Public Health 2022, 22, 757. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Zhang, W.; Chen, S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet 2022, 399, 2011–2012. [Google Scholar] [CrossRef]
- Layer, E.; Hoehl, S.; Widera, M.; Bojkova, D.; Westphal, T.; Gottschalk, R.; Boeddinghaus, B.; Schork, J.; Ciesek, S.; Goetsch, U. SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach. Int. J. Infect. Dis. 2022, 118, 126–131. [Google Scholar] [CrossRef]
- Tenforde, M.W.; Self, W.H.; Adams, K.; Gaglani, M.; Ginde, A.A.; McNeal, T.; Ghamande, S.; Douin, D.J.; Talbot, H.K.; Casey, J.D. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 2021, 326, 2043–2054. [Google Scholar] [CrossRef] [PubMed]
- Belik, M.; Jalkanen, P.; Lundberg, R.; Reinholm, A.; Laine, L.; Väisänen, E.; Skön, M.; Tähtinen, P.A.; Ivaska, L.; Pakkanen, S.H. Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants. Nat. Commun. 2022, 13, 2476. [Google Scholar] [CrossRef]
- Bar-On, Y.M.; Goldberg, Y.; Mandel, M.; Bodenheimer, O.; Freedman, L.; Kalkstein, N.; Mizrahi, B.; Alroy-Preis, S.; Ash, N.; Milo, R. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N. Engl. J. Med. 2021, 385, 1393–1400. [Google Scholar] [CrossRef]
- Dramé, M.; Teguo, M.T.; Proye, E.; Hequet, F.; Hentzien, M.; Kanagaratnam, L.; Godaert, L. Should RT–PCR be considered a gold standard in the diagnosis of COVID-19? J. Med. Virol. 2020, 92, 2312–2313. [Google Scholar] [CrossRef]
- López Seguí, F.; Navarrete Duran, J.M.; Tuldrà, A.; Sarquella, M.; Revollo, B.; Llibre, J.M.; Ara del Rey, J.; Estrada Cuxart, O.; Paredes Deirós, R.; Hernández Guillamet, G. Impact of mass workplace COVID-19 rapid testing on health and healthcare resource savings. Int. J. Environ. Res. Public Health 2021, 18, 7129. [Google Scholar] [CrossRef]
- López Seguí, F.; Estrada Cuxart, O.; Mitjà i Villar, O.; Hernández Guillamet, G.; Prat Gil, N.; Maria Bonet, J.; Isnard Blanchar, M.; Moreno Millan, N.; Blanco, I.; Vilar Capella, M. A cost-benefit analysis of the COVID-19 asymptomatic mass testing strategy in the north Metropolitan area of Barcelona. Int. J. Environ. Res. Public Health 2021, 18, 7028. [Google Scholar] [CrossRef]
- Mina, M.J.; Parker, R.; Larremore, D.B. Rethinking COVID-19 test sensitivity—A strategy for containment. N. Engl. J. Med. 2020, 383, e120. [Google Scholar] [CrossRef] [PubMed]
- Nunes, A.; Jha, P. Rethinking routine airline testing during COVID-19. Nat. Hum. Behav. 2022, 6, 310. [Google Scholar] [CrossRef] [PubMed]
- Godin, B. On the origins of bibliometrics. Scientometrics 2006, 68, 109–133. [Google Scholar] [CrossRef]
- Yeung, A.W.K.; Souto, E.B.; Durazzo, A.; Lucarini, M.; Novellino, E.; Tewari, D.; Wang, D.; Atanasov, A.G.; Santini, A. Big impact of nanoparticles: Analysis of the most cited nanopharmaceuticals and nanonutraceuticals research. Curr. Res. Biotechnol. 2020, 2, 53–63. [Google Scholar] [CrossRef]
- Yeung, A.W.K.; Tzvetkov, N.T.; Georgieva, M.G.; Ognyanov, I.V.; Kordos, K.; Jóźwik, A.; Kühl, T.; Perry, G.; Petralia, M.C.; Mazzon, E.; et al. Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis. Antioxid. Redox Signal. 2021, 34, 402–420. [Google Scholar] [CrossRef] [PubMed]
- Yeung, A.W.K.; Tzvetkov, N.T.; Jóźwik, A.; Horbanczuk, O.K.; Polgar, T.; Pieczynska, M.D.; Sampino, S.; Nicoletti, F.; Berindan-Neagoe, I.; Battino, M. Food toxicology: Quantitative analysis of the research field literature. Int. J. Food Sci. Nutr. 2020, 71, 13–21. [Google Scholar] [CrossRef]
- World Health Organization. Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection. Available online: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-SARS-CoV-2infection-using-rapid-immunoassays (accessed on 6 July 2022).
- Dinnes, J.; Deeks, J.J.; Adriano, A.; Berhane, S.; Davenport, C.; Dittrich, S.; Emperador, D.; Takwoingi, Y.; Cunningham, J.; Beese, S.; et al. Rapid, point-of-care antigen and molecular–based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2020, 8, CD013705. [Google Scholar]
- Dinnes, J.; Deeks, J.J.; Berhane, S.; Taylor, M.; Adriano, A.; Davenport, C.; Dittrich, S.; Emperador, D.; Takwoingi, Y.; Cunningham, J.; et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2021, 3, CD013705. [Google Scholar]
- Turcato, G.; Zaboli, A.; Pfeifer, N.; Ciccariello, L.; Sibilio, S.; Tezza, G.; Ausserhofer, D. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report. J. Infect. 2021, 82, e14–e16. [Google Scholar] [CrossRef]
- Möckel, M.; Corman, V.M.; Stegemann, M.S.; Hofmann, J.; Stein, A.; Jones, T.C.; Gastmeier, P.; Seybold, J.; Offermann, R.; Bachmann, U. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers 2021, 26, 213–220. [Google Scholar] [CrossRef]
- Caruana, G.; Lebrun, L.-L.; Aebischer, O.; Opota, O.; Urbano, L.; de Rham, M.; Marchetti, O.; Greub, G. The dark side of SARS-CoV-2 rapid antigen testing: Screening asymptomatic patients. New Microbes New Infect. 2021, 42, 100899. [Google Scholar] [CrossRef] [PubMed]
- Loconsole, D.; Sallustio, A.; Accogli, M.; Leaci, A.; Sanguedolce, A.; Parisi, A.; Chironna, M. Investigation of an outbreak of symptomatic SARS-CoV-2 VFor duplicate references, please replace one of them with a new reference if needed and ensure that there are no duplicated references. Or we will help delete one and re-arrange the reference order. Please just make sure that all references are cited in main text.OC 202012/01-lineage B. 1.1. 7 infection in healthcare workers, Italy. Clin. Microbiol. Infect. 2021, 27, e1171–e1174. [Google Scholar]
- Rodger, D.; Blackshaw, B.P. COVID-19 vaccination should not be mandatory for health and social care workers. New Bioeth. 2022, 28, 27–39. [Google Scholar] [CrossRef]
- Haller, S.; Güsewell, S.; Egger, T.; Scanferla, G.; Thoma, R.; Leal-Neto, O.B.; Flury, D.; Brucher, A.; Lemmenmeier, E.; Möller, J.C. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: A prospective multicentre cohort. Antimicrob. Resist. Infect. Control 2022, 11, 27. [Google Scholar] [CrossRef] [PubMed]
- Revollo, B.; Blanco, I.; Soler, P.; Toro, J.; Izquierdo-Useros, N.; Puig, J.; Puig, X.; Navarro-Pérez, V.; Casañ, C.; Ruiz, L. Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: A randomised controlled trial. Lancet Infect. Dis. 2021, 21, 1365–1372. [Google Scholar] [CrossRef]
- Walsh, K.A.; Tyner, B.; Broderick, N.; Harrington, P.; O’Neill, M.; Fawsitt, C.G.; Cardwell, K.; Smith, S.M.; Connolly, M.A.; Ryan, M. Effectiveness of public health measures to prevent the transmission of SARS-CoV-2 at mass gatherings: A rapid review. Rev. Med. Virol. 2021, 12, e2285. [Google Scholar] [CrossRef]
- Torres, J.R. Are rapid antigen SARS-Cov-2 tests effective for mass screening of travelers at airports? The Olympic experience. J. Travel Med. 2021, 28, taab135. [Google Scholar] [CrossRef]
- Colavita, F.; Vairo, F.; Meschi, S.; Valli, M.B.; Lalle, E.; Castilletti, C.; Fusco, D.; Spiga, G.; Bartoletti, P.; Ursino, S. COVID-19 Rapid antigen test as screening strategy at points of entry: Experience in Lazio region, central Italy, August–October 2020. Biomolecules 2021, 11, 425. [Google Scholar] [CrossRef]
- Bielecki, M.; Patel, D.; Hinkelbein, J.; Komorowski, M.; Kester, J.; Ebrahim, S.; Rodriguez-Morales, A.J.; Memish, Z.A.; Schlagenhauf, P. Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review. Travel. Med. Infect. Dis. 2020, 38, 101939. [Google Scholar] [CrossRef]
- Schulte, P.A.; Piacentino, J.D.; Weissman, D.N.; de Perio, M.A.; Chiu, S.K.; Radonovich, L.J.; Trout, D.; Beezhold, D.; Hearl, F.J.; Howard, J. Proposed framework for considering SARS-CoV-2 antigen testing of unexposed asymptomatic workers in selected workplaces. J. Occup. Environ. Med. 2021, 63, 646–656. [Google Scholar] [CrossRef]
- Kaiser, M.S.; Mahmud, M.; Noor, M.B.T.; Zenia, N.Z.; Al Mamun, S.; Mahmud, K.A.; Azad, S.; Aradhya, V.M.; Stephan, P.; Stephan, T. iWorkSafe: Towards healthy workplaces during COVID-19 with an intelligent pHealth App for industrial settings. IEEE Access 2021, 9, 13814–13828. [Google Scholar] [CrossRef]
- Rosella, L.C.; Agrawal, A.; Gans, J.; Goldfarb, A.; Sennik, S.; Stein, J. Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces. Sci. Adv. 2022, 8, eabm3608. [Google Scholar] [CrossRef] [PubMed]
- Tsujimoto, Y.; Terada, J.; Kimura, M.; Moriya, A.; Motohashi, A.; Izumi, S.; Kawajiri, K.; Hakkaku, K.; Morishita, M.; Saito, S. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR. Infect. Dis. 2021, 53, 581–589. [Google Scholar] [CrossRef] [PubMed]
- Butler-Laporte, G.; Lawandi, A.; Schiller, I.; Yao, M.; Dendukuri, N.; McDonald, E.G.; Lee, T.C. Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: A systematic review and meta-analysis. JAMA Intern. Med. 2021, 181, 353–360. [Google Scholar] [CrossRef]
- Bastos, M.L.; Perlman-Arrow, S.; Menzies, D.; Campbell, J.R. The sensitivity and costs of testing for SARS-CoV-2 infection with saliva versus nasopharyngeal swabs: A systematic review and meta-analysis. Ann. Intern. Med. 2021, 174, 501–510. [Google Scholar] [CrossRef]
- Franceschini, F.; Maisano, D.; Mastrogiacomo, L. The museum of errors/horrors in Scopus. J. Informetr. 2016, 10, 174–182. [Google Scholar] [CrossRef]
Entities | N (%) | Citations per Publication (CPP) |
---|---|---|
Authors (6 authors co-ranked 3rd) | ||
Nakamura, Koji | 10 (1.0) | 4.0 |
Kirking, Hannah L | 9 (0.9) | 12.9 |
Akashi, Yusaku | 8 (0.8) | 4.1 |
Notake, Shigeyuki | 8 (0.8) | 4.1 |
Suzuki, Hiromichi | 8 (0.8) | 4.1 |
Takeuchi, Yuto | 8 (0.8) | 4.1 |
Tate, Jacqueline E | 8 (0.8) | 14.5 |
Ueda, Atsuo | 8 (0.8) | 4.1 |
Institutions (2 of them co-ranked 5th) | ||
University of California system | 37 (3.7) | 7.5 |
University of London | 37 (3.7) | 14.4 |
Centers for Disease Control and Prevention (CDC, USA) | 25 (2.5) | 11.9 |
Harvard University | 24 (2.4) | 44.4 |
German Center for Infection Research | 22 (2.2) | 19.3 |
Imperial College London | 22 (2.2) | 6.7 |
Countries/regions | ||
United States of America | 266 (26.6) | 10.9 |
England | 120 (12.0) | 15.6 |
Germany | 98 (9.8) | 8.9 |
India | 70 (7.0) | 3.7 |
Italy | 62 (6.2) | 10.1 |
Journals | ||
Diagnostics | 35 (3.5) | 3.6 |
International Journal of Infectious Diseases | 32 (3.2) | 15.8 |
Journal of Clinical Virology | 27 (2.7) | 40.0 |
BMJ British Medical Journal | 24 (2.4) | 7.6 |
PLoS ONE | 23 (2.3) | 3.8 |
Journal categories | ||
Infectious Diseases | 210 (21.0) | 10.8 |
Medicine General Internal | 204 (20.4) | 11.1 |
Public Environmental Occupational Health | 112 (11.2) | 3.6 |
Microbiology | 107 (10.7) | 13.6 |
Virology | 78 (7.8) | 18.0 |
Author Keyword | N (%) | Citations per Publication (CPP) |
---|---|---|
COVID-19 | 470 | 8.8 |
SARS-CoV-2 | 416 | 10.3 |
Antigen test | 74 | 8.9 |
Rapid antigen test | 68 | 5.9 |
RT-PCR | 59 | 13.4 |
Antigen | 41 | 16.3 |
Diagnosis | 35 | 14.3 |
Sensitivity | 32 | 5.8 |
Coronavirus | 31 | 15.8 |
Antigen testing | 30 | 6.1 |
PCR | 25 | 7.3 |
Point-of-care | 23 | 8.0 |
Specificity | 23 | 4.8 |
Public health | 21 | 6.1 |
Pandemic | 20 | 1.9 |
Epidemiology | 19 | 3.2 |
Point-of-care testing | 19 | 16.1 |
Screening | 19 | 4.6 |
Self-testing | 19 | 4.3 |
Rapid antigen tests | 18 | 5.0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yeung, A.W.K.; Parvanov, E.D.; Nawaz, F.A.; Rayan, R.A.; Kletecka-Pulker, M.; Willschke, H.; Atanasov, A.G. COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature. Int. J. Environ. Res. Public Health 2022, 19, 12493. https://doi.org/10.3390/ijerph191912493
Yeung AWK, Parvanov ED, Nawaz FA, Rayan RA, Kletecka-Pulker M, Willschke H, Atanasov AG. COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature. International Journal of Environmental Research and Public Health. 2022; 19(19):12493. https://doi.org/10.3390/ijerph191912493
Chicago/Turabian StyleYeung, Andy Wai Kan, Emil D. Parvanov, Faisal A. Nawaz, Rehab A. Rayan, Maria Kletecka-Pulker, Harald Willschke, and Atanas G. Atanasov. 2022. "COVID-19 Rapid Antigen Tests: Bibliometric Analysis of the Scientific Literature" International Journal of Environmental Research and Public Health 19, no. 19: 12493. https://doi.org/10.3390/ijerph191912493